P-54-FP

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameP-54-FP
Drug Alias NameP-54FPP-54-FPP-54
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionNuclear factor NF-kappa-B complex inhibitorsCyclooxygenase-2 inhibitors
TargetsCyclooxygenase-2Nuclear factor NF-kappa-B complex
Therapy Area/IndicationsCrohn DiseaseInflammatory Bowel DiseasesColitis, Ulcerative +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesIxico Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIxico Ltd
Active IndicationsN/A
Inactive IndicationsCrohn DiseaseInflammatory Bowel DiseasesColitis, Ulcerative +[4] 

Other Information

ATC CodeN/A
Related LinksN/A